For citations:
Ivakhnenko O.I., Derkach E.V., Krysanova V.S., Ermolaeva A.D., Kokushkin K.A. Mirabegron: pharmacoeconomic aspects of the use of the drug for the treatment of overactive bladder syndrome. Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice. 2022;(1):30-40. (In Russ.) https://doi.org/10.37489/2588-0519-2022-1-30-40